These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18048237)

  • 21. Global support for new vaccine implementation in middle-income countries.
    Kaddar M; Schmitt S; Makinen M; Milstien J
    Vaccine; 2013 Apr; 31 Suppl 2():B81-96. PubMed ID: 23598496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the use of economics in vaccine expert reviews.
    Jacobs P; Ohinmaa A
    Vaccine; 2010 Apr; 28(16):2841-5. PubMed ID: 20153796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forecasting demand for Hib-containing vaccine in the world's poorest countries: a 4-year prospective experience.
    Zuber PL; Dumolard L; Shirey M; Rizzo I; Marshall J
    Vaccine; 2009 Jan; 27(3):410-5. PubMed ID: 19013493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.
    Andrus JK; Sherris J; Fitzsimmons JW; Kane MA; Aguado MT
    Vaccine; 2008 Aug; 26 Suppl 10():K87-92. PubMed ID: 18847561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunisation registers in Canada: progress made, current situation, and challenges for the future.
    Laroche JA; Diniz AJ
    Euro Surveill; 2012 Apr; 17(17):. PubMed ID: 22551496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basis for vaccine recommendations].
    Lévy-Bruhl D
    Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
    Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
    Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forecasting daily patient volumes in the emergency department.
    Jones SS; Thomas A; Evans RS; Welch SJ; Haug PJ; Snow GL
    Acad Emerg Med; 2008 Feb; 15(2):159-70. PubMed ID: 18275446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
    Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
    Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of vaccine supply chains to everyone in the vaccine world.
    Lee BY; Haidari LA
    Vaccine; 2017 Aug; 35(35 Pt A):4475-4479. PubMed ID: 28629921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunizations in the United States: success, structure, and stress.
    Orenstein WA; Douglas RG; Rodewald LE; Hinman AR
    Health Aff (Millwood); 2005; 24(3):599-610. PubMed ID: 15886150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community pharmacy influenza immunisation increases vaccine uptake and gains public approval.
    Hook S; Windle J
    Aust N Z J Public Health; 2013 Oct; 37(5):489-90. PubMed ID: 24090334
    [No Abstract]   [Full Text] [Related]  

  • 34. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.
    Al Awaidy S
    Vaccine; 2010 Apr; 28 Suppl 1():A39-41. PubMed ID: 20412995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New vaccine adoption in lower-middle-income countries.
    Makinen M; Kaddar M; Molldrem V; Wilson L
    Health Policy Plan; 2012 May; 27 Suppl 2():ii39-49. PubMed ID: 22513731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine stability in the context of vaccine delivery in a developing country: India.
    John TJ
    Dev Biol Stand; 1996; 87():19-25. PubMed ID: 8853998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral vaccines: new needs, new possibilities.
    Aziz MA; Midha S; Waheed SM; Bhatnagar R
    Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Advisory Groups and their role in immunization policy-making processes in European countries.
    Nohynek H; Wichmann O; D Ancona F;
    Clin Microbiol Infect; 2013 Dec; 19(12):1096-105. PubMed ID: 23957860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision support in vaccination policies.
    Piso B; Wild C
    Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.